Skip to main content
. 2018 May 24;13(5):e0197583. doi: 10.1371/journal.pone.0197583

Fig 5. Forest plot of pooled odds ratios (with 95% CI) of various adverse drug events for FDA-approved direct oral anticoagulants versus warfarin for treatment of VTE.

Fig 5